An open-label phase II study of lenvatinib plus pembrolizumab in patients with advanced gastric cancer (EPOC1706)

被引：0
|
作者：
Kawazoe, Akihito
Fukuoka, Shota
Nakamura, Yoshiaki
Kuboki, Yasutoshi
Mikamoto, Yuichi
Shima, Hikari
Fujishiro, Noriko
Higuchi, Tsukiko
Wakabayashi, Masashi
Nomura, Shogo
Sato, Akihiro
Shitara, Kohei
机构：
[1] Natl Canc Ctr Hop East, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr Hosp East, Clin Res Support Off, Kashiwa, Chiba, Japan
[4] Natl Canc Ctr Hosp East, Ctr Res Adm & Support, Kashiwa, Chiba, Japan
[5] Natl Canc Ctr, Operat Off, JCOG Data Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
374
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial
    Kawazoe, Akihito
    Fukuoka, Shota
    Nakamura, Yoshiaki
    Kuboki, Yasutoshi
    Wakabayashi, Masashi
    Nomura, Shogo
    Mikamoto, Yuichi
    Shima, Hikari
    Fujishiro, Noriko
    Higuchi, Tsukiko
    Sato, Akihiro
    Kuwata, Takeshi
    Shitara, Kohei
    [J]. LANCET ONCOLOGY, 2020, 21 (08): : 1057 - 1065
  • [2] Phase 2 open-label study of pembrolizumab plus lenvatinib and belzutifan in patients with advanced solid tumors
    Kelley, Robin Kate
    Van Cutsem, Eric
    Lee, Michael Sangmin
    Wolf, Ido
    Fakih, Marwan
    De Vos-Geelen, Judith De
    Lee, Valerie
    Vogel, Arndt
    Wu, Larry
    Jin, Fan
    Naik, Girish S.
    O'Reilly, Eileen Mary
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Phase 2 open-label study of pembrolizumab plus lenvatinib and belzutifan in patients with advanced solid tumors
    Kelley, Robin Kate
    Van Cutsem, Eric
    Lee, Michael S.
    Wolf, Ido
    Fakih, Marwan
    de Vos-Geelen, Judith
    Lee, Valerie
    Vogel, Arndt
    Wu, Xi Lawrence
    Jin, Fan
    Naik, Girish S.
    O'Reilly, Eileen Mary
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [4] An open-label phase 2 study of lenvatinib plus pembrolizumab in the neoadjuvant and adjuvant treatment for patients with gastric and gastroesophageal junction adenocarcinoma (EPOC2001)
    Kawazoe, Akihito
    Wakabayashi, Masashi
    Furuya, Hideki
    Sato, Akihiro
    Sakamoto, Naoya
    Kuwata, Takeshi
    Kinoshita, Takahiro
    Shitara, Kohei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [5] An open-label phase 1 trial of lenvatinib plus pembrolizumab in patients with advanced selected solid tumors
    Kitano, Shigehisa
    Fujiwara, Yutaka
    Shimizu, Toshio
    Iwasa, Satoru
    Yonemori, Kan
    Kondo, Shunsuke
    Shimomura, Akihiko
    Koyama, Takafumi
    Ebata, Takahiro
    Iizumi, Sakura
    Ikezawa, Hiroki
    Namiki, Masayuki
    Kubota, Tomoki
    Miura, Takuma
    Yamamoto, Noboru
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [6] Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
    Makker, Vicky
    Rasco, Drew
    Vogelzang, Nicholas J.
    Brose, Marcia S.
    Cohn, Allen L.
    Mier, James
    Di Simone, Christopher
    Hyman, David M.
    Stepan, Daniel E.
    Dutcus, Corina E.
    Schmidt, Emmett V.
    Guo, Matthew
    Sachdev, Pallavi
    Shumaker, Robert
    Aghajanian, Carol
    Taylor, Matthew
    [J]. LANCET ONCOLOGY, 2019, 20 (05): : 711 - 718
  • [7] A multicenter, open-label phase II trial of secondline apatinib plus irinotecan in patients with advanced gastric cancer
    Peng, Jianjun
    Li, Yong
    Xiao, Jianjun
    Liu, Huaqiang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [8] Phase II open-label study of sunitinib in patients with advanced breast cancer
    Denise A. Yardley
    E. Claire Dees
    Stephen D. Myers
    Sherry Li
    Paul Healey
    Zhixiao Wang
    Marla J. Brickman
    Jolanda Paolini
    Kenneth A. Kern
    Dennis L. Citrin
    [J]. Breast Cancer Research and Treatment, 2012, 136 : 759 - 767
  • [9] Phase II open-label study of sunitinib in patients with advanced breast cancer
    Yardley, Denise A.
    Dees, E. Claire
    Myers, Stephen D.
    Li, Sherry
    Healey, Paul
    Wang, Zhixiao
    Brickman, Marla J.
    Paolini, Jolanda
    Kern, Kenneth A.
    Citrin, Dennis L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (03) : 759 - 767
  • [10] Phase II study of lenvatinib plus pembrolizumab for patients with immunotherapy-naive advanced gastric cancer following first line therapy
    Cohen, Deirdre Jill
    Lee, Jonathan W.
    Becker, Daniel Jacob
    Siolas, Despina
    Beri, Nina
    Ryan, Theresa
    Kozuch, Peter
    Yu, Shun
    Levinson, Benjamin A.
    Goldberg, Judith D.
    Leichman, Lawrence P.
    Oberstein, Paul Eliezer
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345